Patent · US Active

GLA domains as therapeutic agents

US10925926B2 · kind B2 · utility

1Cited by

23References

13Claims

0Family size

Assignee

GLADIATOR BIOSCIENCES, INC. · US

Inventors

Maxine Bauzon · Hercules, US
Terry Hermiston · Corte Madera, US

Key dates

Filing date	Oct 25, 2018
Grant date	Feb 23, 2021
Priority date	—
Expiry date	Oct 25, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure relates to the recombinant Gla domain proteins and their use targeting phosphatidylserine (PtdS) moieties on the surface of cells, particularly those expressing elevated levels of PtdS, such as cells undergoing apoptosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.